Clinical Trials Browser

Phase 3 × Pancreatic Neoplasms × vapreotide × Clear all

NCT00014651 2010-08-10

Vapreotide in Treating Patients Undergoing Elective Pancreatic Resection

Phase 3 Terminated

Gastrointestinal

Pancreatic Neoplasms, Postoperative Complications